new_adrs_0322_1336|AURA|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_adrs_0322_1336|AURA|1|Aura Biosciences Inc Total Current Assets (Quarterly) (USD)|Aura Biosciences Inc Cash and Short Term Investments (Quarterly) (USD)|Aura Biosciences Inc Inventories (Quarterly) (USD)|Aura Biosciences Inc Net PP&E (Quarterly) (USD)|Aura Biosciences Inc Goodwill and Intangibles (Quarterly) (USD)|Aura Biosciences Inc Total Liabilities (Quarterly) (USD)|Aura Biosciences Inc Total Current Liabilities (Quarterly) (USD)|Aura Biosciences Inc Total Long Term Liabilities (Quarterly) (USD)|Aura Biosciences Inc Total Deposits (Quarterly) (USD)|Aura Biosciences Inc Book Value (Quarterly) (USD)|Aura Biosciences Inc Retained Earnings (Quarterly) (USD)|Aura Biosciences Inc Treasury Stock (Quarterly) (USD)|Aura Biosciences Inc EV to Revenues|Aura Biosciences Inc EV to Earnings|Aura Biosciences Inc EV to Free Cash Flow|Aura Biosciences Inc EV to Assets (Quarterly)|Aura Biosciences Inc PS Ratio|Aura Biosciences Inc PE Ratio|Aura Biosciences Inc Price to Book Value|Aura Biosciences Inc PEG Ratio|Aura Biosciences Inc Debt to Equity Ratio|Aura Biosciences Inc Dividend Yield|Aura Biosciences Inc Shareholder Yield (TTM)|Aura Biosciences Inc Percent of Shares Outstanding Short|Aura Biosciences Inc Total Receivables (Quarterly) (USD)|Aura Biosciences Inc Total Payables (Quarterly) (USD)|Aura Biosciences Inc Total Capital Stock (Quarterly) (USD)|Aura Biosciences Inc Return on Invested Capital|Aura Biosciences Inc Quality Ratio Score|Aura Biosciences Inc Momentum Score|Aura Biosciences Inc Beta (1Y)|Aura Biosciences Inc Sustainable Growth Rate (TTM)|Aura Biosciences Inc Institutional Investor Ownership Percentage|Aura Biosciences Inc Average Diluted Shares Outstanding (Quarterly)|Aura Biosciences Inc Total Employees (Annual)|Aura Biosciences Inc EPS Diluted (Quarterly) (USD)|Aura Biosciences Inc Shares Outstanding|Aura Biosciences Inc Repurchase of Capital Stock (Quarterly) (USD)|Aura Biosciences Inc Ordinary Shares Number (Quarterly)|Aura Biosciences Inc Payout Ratio|Aura Biosciences Inc Quick Ratio (Quarterly)|Aura Biosciences Inc Normalized Diluted EPS (Quarterly) (USD)|Aura Biosciences Inc Stock Buybacks (Quarterly) (USD)|Aura Biosciences Inc Effective Tax Rate (TTM)|Aura Biosciences Inc Return on Equity|Aura Biosciences Inc Net Income (TTM) (USD)|Aura Biosciences Inc Revenue (TTM) (USD)|Aura Biosciences Inc Dividend Per Share (Quarterly) (USD)|Aura Biosciences Inc Revenue (Quarterly) (USD)|Aura Biosciences Inc Gross Profit (Quarterly) (USD)|Aura Biosciences Inc SG&A Expense (Quarterly) (USD)|Aura Biosciences Inc Pre-Tax Income (Quarterly) (USD)|Aura Biosciences Inc Net Income (Quarterly) (USD)|Aura Biosciences Inc Net Interest Income (Quarterly) (USD)|Aura Biosciences Inc Price (USD)|Aura Biosciences Inc Total Return Price (USD)|Aura Biosciences Inc Enterprise Value (USD)|Aura Biosciences Inc 30-Day Average Daily Volume|Aura Biosciences Inc 1 Year Price Returns (Daily)||
new_adrs_0322_1336|AURA|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_adrs_0322_1336|AURA|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly||
new_adrs_0322_1336|AURA|5|136.5|136.5||136.5||136.5|136.5|136.5||136.5|136.5|||||||||||1.45833333333||15.25||136.5|136.5||||||30|182.5||182.5|12.5||136.5|||182.5|||||||||182.5|182.5|182.5|182.5|1.45833333333|1.45833333333|1.45833333333|1.46268656716|||
new_adrs_0322_1336|AURA|6|2|2||2||2|2|2||2|2|||||||||||96||8||2|2||||||4|2||2|2||2|||2|||||||||2|2|2|2|96|96|96|67|||
new_adrs_0322_1336|AURA|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_adrs_0322_1336|AURA|202009||||||||||||||||||||||||||||||||||19.5655||-0.1856||||||-0.1856|||||||||0.781|-3.631|-3.631||||||||
new_adrs_0322_1336|AURA|202012|18.455|17.393||3.574||130.817|2.661|128.156||-108.713|-116.886|||||||||||||||0.611||||||||19.5655||-0.2508|||28.0096|||-0.2508|||||||||1.366|-4.907|-4.907|-0.001|||||||
new_adrs_0322_1336|AURA|202106|92.875|92.197||5.318||221.404|5.316|216.088||-122.751|-131.665|||||||||||||||2.417|||||||||||||28.0096||||||||||||||||||||||
new_adrs_0322_1336|AURA|202109|83.458|81.829||5.538||22.993|5.831|17.162||-131.015|-140.503|||||||||||||0.3917||1.736|198.726||||||0.576|28.0096|42|-0.3155|28.4096||28.0096|||-0.3155|||||||||2.53|-8.838|-8.838|0.005|14.8|14.8|537.3591|||17.44|
new_adrs_0322_1336|AURA|202112||||||||||||||||||||||||0.3442|||||||||60.3664||||||||||||||||||||||16.98|16.98|612.8913|120679.1||18.25|17.9
new_adrs_0322_1336|AURA|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||22|22|759.528|29203.5|||